Pfizer has initiated a voluntary recall of one batch of its Norvasc generic amlodipine tablets after discovering that bottles labeled as 5 mg tablets actually contain 10 mg tablets. The mix-up affects lot number NV26-0418 distributed to pharmacies in 12 states.
Patients taking the incorrect higher dose could experience dangerously low blood pressure, dizziness, and fainting. Pfizer is urging pharmacies to quarantine affected inventory and patients to verify their medication with their pharmacist.
The company has traced the error to a packaging line malfunction at a manufacturing facility in New Jersey and says corrective measures have been implemented.
